Search Results - "Jallal, B"

Refine Results
  1. 1

    A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth by Streicher, K L, Zhu, W, Lehmann, K P, Georgantas, R W, Morehouse, C A, Brohawn, P, Carrasco, R A, Xiao, Z, Tice, D A, Higgs, B W, Richman, L, Jallal, B, Ranade, K, Yao, Y

    Published in Oncogene (22-03-2012)
    “…Malignant melanoma is the most aggressive form of skin cancer and its incidence has doubled in the last two decades. It represents only 4% of skin cancer cases…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis by Greenberg, S A, Higgs, B W, Morehouse, C, Walsh, R J, Won Kong, S, Brohawn, P, Zhu, W, Amato, A, Salajegheh, M, White, B, Kiener, P A, Jallal, B, Yao, Y

    Published in Genes and immunity (01-04-2012)
    “…The objective of this study was to evaluate the relationship between blood mRNA, disease activity and treatment effects in a longitudinal study of patients…”
    Get full text
    Journal Article
  4. 4

    Pharmacogenomics and Translational Simulations to Bridge Indications for an Anti-Interferon-α Receptor Antibody by Wang, B, Higgs, B W, Chang, L, Vainshtein, I, Liu, Z, Streicher, K, Liang, M, White, W I, Yoo, S, Richman, L, Jallal, B, Roskos, L, Yao, Y

    Published in Clinical pharmacology and therapeutics (01-06-2013)
    “…A type I interferon (IFN) gene signature shared by systemic lupus erythematous (SLE) and systemic sclerosis (SSc) was used to evaluate an anti‐type I IFN‐α…”
    Get full text
    Journal Article
  5. 5

    Heregulin‐dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3 by Wallasch, C., Weiss, F. U., Niederfellner, G., Jallal, B., Issing, W., Ullrich, A.

    Published in The EMBO journal (01-09-1995)
    “…Amplification and/or overexpression of HER2/neu and HER3 genes have been implicated in the development of cancer in humans. The fact that these receptor…”
    Get full text
    Journal Article
  6. 6

    Interaction of Vav with ENX-1, a putative transcriptional regulator of homeobox gene expression by Hobert, Oliver, Jallal, Bahija, Ullrich, Axel

    Published in Molecular and Cellular Biology (01-06-1996)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  7. 7

    The secreted tumor-associated antigen 90K is a potent immune stimulator by ULLRICH, A, SURES, I, SHAWVER, L. K, SCHLESSINGER, J, IACOBELLI, S, D'EGIDIO, M, JALLAL, B, POWELL, T. J, HERBST, R, DREPS, A, MOHAMMAD AZAM, RUBINSTEIN, M, NATOLI, C

    Published in The Journal of biological chemistry (15-07-1994)
    “…Immunization of mice with conditioned media from human breast cancer cells yielded the monoclonal antibody SP-2, which recognized an antigen of approximately…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Tyrosine phosphatase inhibition permits analysis of signal transduction complexes in p185HER2/neu-overexpressing human tumor cells by JALLAL, B, SCHLESSINGER, J, ULLRICH, A

    Published in The Journal of biological chemistry (05-03-1992)
    “…The HER2/neu gene encodes a receptor tyrosine kinase that is highly homologous to the epidermal growth factor receptor. Overexpression of the receptor in…”
    Get full text
    Journal Article
  12. 12

    Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNα antibody, in systemic lupus erythematosus by Yao, Yihong, Higgs, Brandon W, Richman, Laura, White, Barbara, Jallal, Bahija

    Published in Arthritis research & therapy (01-01-2010)
    “…Type I interferons are implicated in the pathogenesis of systemic lupus erythematosus (SLE). Type I interferon-inducible mRNAs are widely and concordantly…”
    Get full text
    Journal Article
  13. 13

    Novel signaling pathway suggested by SH3 domain-mediated p95vav/heterogeneous ribonucleoprotein K interaction by HOBERT, O, BAHIJA JALLAL, SCHLESSINGER, J, ULLRICH, A

    Published in The Journal of biological chemistry (12-08-1994)
    “…The role of the protooncogene product p95vav in signal transduction was investigated by characterizing its interactions with proteins that may represent…”
    Get full text
    Journal Article
  14. 14

    PAK4 mediates morphological changes through the regulation of GEF-H1 by Callow, Marinella G, Zozulya, Sergey, Gishizky, Mikhail L, Jallal, Bahija, Smeal, Tod

    Published in Journal of cell science (01-05-2005)
    “…Precise spatial and temporal regulation of Rho GTPases is required in controlling F-actin-based changes in cell morphology. The molecular mechanisms through…”
    Get full text
    Journal Article
  15. 15

    Monoclonal antibodies against luteinizing hormone receptor. Immunochemical characterization of the receptor by Vuhai-Luuthi, M T, Jolivet, A, Jallal, B, Salesse, R, Bidart, J M, Houllier, A, Guiochon-Mantel, A, Garnier, J, Milgrom, E

    Published in Endocrinology (Philadelphia) (01-11-1990)
    “…Human CG (hCG)-receptor complexes were solubilized from porcine testicular membranes. They were chromatographed on an immunomatrix of Affi-Gel 10-D1E8 anti…”
    Get more information
    Journal Article
  16. 16

    Requirement for PAK4 in the Anchorage-independent Growth of Human Cancer Cell Lines by Callow, Marinella G., Clairvoyant, Felix, Zhu, Shirley, Schryver, Brian, Whyte, David B., Bischoff, James R., Jallal, Bahija, Smeal, Tod

    Published in The Journal of biological chemistry (04-01-2002)
    “…p21-activated protein kinase (PAK) serine/threonine kinases are important effectors of Rho family GTPases and have been implicated in the regulation of cell…”
    Get full text
    Journal Article
  17. 17

    891 Population Pharmacokinetics Analysis of Motavizumab in Children at Risk for Respiratory Syncytial Virus Infection by Zhao, L, Roskos, L, Griffin, P, Losonsky, G A, Groothuis, J R, Jallal, B, Robbie, G

    Published in Pediatric research (01-11-2010)
    “…Aims: To develop a population pharmacokinetics (PK) model and evaluate the impact of demographic covariates on PK of motavizumab in young children. Methods:…”
    Get full text
    Journal Article
  18. 18

    The transmembrane receptor protein tyrosine phosphatase DEP1 interacts with p120(ctn) by Holsinger, Leslie J, Ward, Kevin, Duffield, Bill, Zachwieja, Joseph, Jallal, Bahija

    Published in Oncogene (10-10-2002)
    “…The receptor-like protein tyrosine phosphatase DEP1, also known as CD148, is expressed predominantly in epithelial cells, in a variety of tumor cell lines, and…”
    Get full text
    Journal Article
  19. 19

    The Serine/Threonine Kinase Nek6 Is Required for Cell Cycle Progression through Mitosis by Yin, Min-Jean, Shao, Lihua, Voehringer, David, Smeal, Tod, Jallal, Bahija

    Published in The Journal of biological chemistry (26-12-2003)
    “…The Aspergillus nidulans protein NIMA (never in mitosis, gene A) is a protein kinase required for the initiation of mitosis, whereas its inactivation is…”
    Get full text
    Journal Article
  20. 20

    The lymphoid protein tyrosine phosphatase Lyp interacts with the adaptor molecule Grb2 and functions as a negative regulator of T-cell activation by Hill, Ronald J, Zozulya, Sergey, Lu, Ying-Lin, Ward, Kevin, Gishizky, Mikhail, Jallal, Bahija

    Published in Experimental hematology (01-03-2002)
    “…Following activation of T cells, phosphorylation of tyrosine residues occurs through a complex signaling process involving protein tyrosine kinases,…”
    Get full text
    Journal Article